QUALIGEN THERAPEUTICS INC QLGN 深 滬
等待開盤 10-28 09:30:00 美东时间
2.97
-0.670
-18.41%
華盛通- 最 高3.39
- 今 開3.39
- 成交量 166.83万股
- 最 低 2.90
- 昨 收 3.64
- 總市值 162.84万
- 52周最高 8.81
- 市盈率 靜 --
- 換手率 304.28%
- 52周最低 1.61
- 委 比 85.60%
- 總股本 54.83万
- 歷史最高 687500.00
- 量 比 0.13
- 振 幅 13.46%
- 歷史最低 1.61
- 每 手 1
- 風險率 0.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025
Qualigen Therapeutics Inc. (QLGN), owned by Faraday Future, will rebrand as AIxCrypto following its November 12, 2025 stockholder meeting. The company plans to launch its Web3 and crypto initiatives, including a public beta of the BesTrade DeAI Agent by November 2025 and release of its EAI RWA Utility Token Whitepaper. AIxCrypto aims to achieve three milestones by year-end: expand its C10 Treasury to $50 million AUM, accelerate global growth of t...
今天 03:57
Faraday Future Enters UAE Market Through Exclusive Deal
Faraday Future expands to the UAE, signing a strategic deal with RAK Motors. FFAI stock climbs as the partnership sets up complete sales and service ecosystem for FX Super One.
10-24 20:29
Qualigen Therapeutics shares are trading higher after the company announced a strategic partnership with BitGo to support its C10 treasury strategy focused on top cryptocurrencies.
Qualigen Therapeutics shares are trading higher after the company announced a s...
10-24 04:14
Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
Qualigen Therapeutics Inc. (NASDAQ: QLGN), a biotechnology company majority owned by Faraday Future, has entered into a strategic partnership with BitGo, a leading digital asset infrastructure company, to support its C10 treasury strategy. This strategy involves accumulating and compounding a market-cap-weighted basket of the world's top 10 crypto assets (excluding stablecoins). Through this collaboration, Qualigen will leverage BitGo's comprehen...
10-23 20:05
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?
Qualigen Therapeutics, Inc. (NASDAQ: QLGN) announced the launch of its C10 Cryptocurrency Asset Treasury (DAT) purchases, viewing the recent crypto market decline as a strategic opportunity. The market experienced a $16 billion liquidation, driven by geopolitical factors and excessive leverage. QLGN plans to begin purchasing high-quality assets next week, leveraging its SMART Investment Framework, which includes passive defense, active allocation...
10-13 01:00
老币圈人贾跃亭
贾跃亭把币圈玩明白了。 10月8日，他在 X 上发了一张印着“BNB”的汽车图，配文“开币安汽车，享币安人生”。同名 Meme 币“币安汽车”市值应声暴涨，仅几...
10-10 19:48
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
Qualigen Therapeutics appoints Jerry Wang as Co-CEO and Koti Meka as CFO, and expands its Board with Kevin Chen, Chad Chen, and Jay Sheng. The company also transitions its auditor to Macias Gini & O’Connell LLP. These changes aim to enhance leadership, governance, and strategic growth.
10-06 23:00
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Finalizes U.S. Production Assembly Plan
Faraday Future announced the finalization of the U.S. production assembly plan for the FX Super One, with component supply set to commence. The company also reported a significant gain on its $30M investment in QLGN, reflecting nearly 140% unrealized profit. FF showcased its FX Super One and FF 91 at WETEX 2025 in the Middle East, attracting strong interest and paving the way for regional growth. Additionally, the company is strengthening its tea...
10-06 00:00
Qualigen Therapeutics Secures $41M for Crypto Transformation
Qualigen Therapeutics ( ($QLGN) ) just unveiled an announcement. On September 2...
10-04 05:48
